|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 462.95 GBX | -2.25% |
|
+3.33% | +2.77% |
| 08:49pm | Rentokil Initial names OnTrac boss Mike Duffy as new chief executive | AN |
| 08:36pm | Rentokil Initial plc Announces CEO Changes, Effective 16 March 2026 | CI |
| Capitalization | 11.91B 16.04B 13.74B 12.77B 22.25B 1,446B 23.87B 147B 57.84B 692B 60.16B 58.92B 2,536B | P/E ratio 2025 * |
39.4x | P/E ratio 2026 * | 29.8x |
|---|---|---|---|---|---|
| Enterprise value | 14.58B 19.63B 16.81B 15.63B 27.24B 1,769B 29.21B 180B 70.79B 847B 73.63B 72.12B 3,104B | EV / Sales 2025 * |
2.79x | EV / Sales 2026 * | 2.65x |
| Free-Float |
99.75% | Yield 2025 * |
1.85% | Yield 2026 * | 1.97% |
Last Transcript: Rentokil Initial plc
| 1 day | -2.28% | ||
| 1 week | +3.33% | ||
| Current month | +2.77% | ||
| 1 month | +7.60% | ||
| 3 months | +13.05% | ||
| 6 months | +33.69% | ||
| Current year | +2.77% |
| 1 week | 449 |  | 477 |
| 1 month | 422.7 | | 477 |
| Current year | 437 | | 477 |
| 1 year | 306 | | 480 |
| 3 years | 306 | | 663.8 |
| 5 years | 306 | | 663.8 |
| 10 years | 147.4 | | 663.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Ransom
CEO | Chief Executive Officer | 62 | 01/10/2013 |
| Director of Finance/CFO | 54 | 01/01/2025 | |
Mark Purcell
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Ransom
BRD | Director/Board Member | 62 | 27/09/2010 |
Yi-chuang Yueh
BRD | Director/Board Member | 54 | 01/11/2017 |
John Pettigrew
BRD | Director/Board Member | 57 | 01/01/2018 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.27% | 0.96% | 4 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.25% | +3.33% | +20.20% | -11.63% | 16.04B | |
| +0.54% | +3.53% | +32.37% | +62.48% | 29.35B | |
| Average | -0.87% | +4.96% | +26.29% | +25.43% | 22.7B | |
| Weighted average by Cap. | -0.46% | +4.54% | +28.07% | +36.29% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 5.23B 7.04B 6.03B 5.61B 9.76B 634B 10.47B 64.57B 25.38B 304B 26.4B 25.86B 1,113B | 5.42B 7.3B 6.25B 5.81B 10.13B 658B 10.86B 66.96B 26.32B 315B 27.37B 26.81B 1,154B |
| Net income | 302M 407M 348M 324M 565M 36.68B 605M 3.73B 1.47B 17.55B 1.53B 1.49B 64.33B | 397M 535M 458M 426M 742M 48.22B 796M 4.91B 1.93B 23.07B 2.01B 1.97B 84.58B |
| Net Debt | 2.67B 3.59B 3.08B 2.86B 4.98B 324B 5.34B 32.95B 12.95B 155B 13.47B 13.19B 568B | 2.43B 3.27B 2.8B 2.6B 4.54B 295B 4.87B 29.99B 11.79B 141B 12.26B 12.01B 517B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/01/26 | 461.60 p | -2.53% | 1,470,817 |
| 12/01/26 | 473.60 p | +0.47% | 3,465,378 |
| 09/01/26 | 471.40 p | +1.27% | 6,389,036 |
| 08/01/26 | 465.50 p | +0.19% | 3,776,908 |
| 07/01/26 | 464.60 p | +0.98% | 8,998,175 |
Delayed Quote London S.E., 13 January 2026 at 10:52 pm AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- RTO Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition